Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a monosaccharide stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to monosaccharide stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.713 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.418 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.323 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.267 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.259 | ||
| CCNY | cyclin Y | 0.239 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.239 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.196 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.170 | ||
| HDAC3 | histone deacetylase 3 | 0.149 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.128 | Rat | |
| SMAD2 | SMAD family member 2 | 0.122 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.111 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.110 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.110 | ||
| AURKB | aurora kinase B | 0.101 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.100 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.099 | ||
| SMAD3 | SMAD family member 3 | 0.085 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.084 | ||
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.078 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.073 | ||
| AXL | AXL receptor tyrosine kinase | 0.065 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.060 | Human | |
| RANBP9 | RAN binding protein 9 | 0.057 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.057 | ||
| HDAC1 | histone deacetylase 1 | 0.052 | ||
| MPDZ | multiple PDZ domain protein | 0.052 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.046 | ||
| S100B | S100 calcium binding protein B | 0.044 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.040 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.040 | ||
| PLAT | plasminogen activator, tissue | 0.040 | ||
| PLAU | plasminogen activator, urokinase | 0.039 | Rat | |
| PRDX1 | peroxiredoxin 1 | 0.038 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.035 | ||
| IL8 | interleukin 8 | 0.032 | ||
| IRF2 | interferon regulatory factor 2 | 0.028 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.027 | ||
| AKAP11 | A kinase (PRKA) anchor protein 11 | 0.027 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.027 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.026 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.026 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.024 | ||
| PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.024 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.023 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.022 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.021 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.020 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.020 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.020 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.019 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.018 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.018 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.018 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.018 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.018 | ||
| CCND3 | cyclin D3 | 0.017 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.017 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.016 | ||
| MYOG | myogenin (myogenic factor 4) | 0.016 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.016 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.015 | ||
| HIC1 | hypermethylated in cancer 1 | 0.015 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.015 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.015 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.015 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.015 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.014 | ||
| ONECUT1 | one cut homeobox 1 | 0.014 | ||
| GAS2L3 | growth arrest-specific 2 like 3 | 0.014 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.014 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.014 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.014 | ||
| PML | promyelocytic leukemia | 0.013 | ||
| PTEN | phosphatase and tensin homolog | 0.013 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.012 | ||
| MYO16 | myosin XVI | 0.012 | ||
| MYOCD | myocardin | 0.012 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.012 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.012 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.012 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.012 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.012 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.012 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.011 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.011 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.011 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.011 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.011 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.011 | Mouse | |
| YAP1 | Yes-associated protein 1 | 0.011 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.011 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.011 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.010 | ||
| TJP2 | tight junction protein 2 (zona occludens 2) | 0.010 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.010 | ||
| ATN1 | atrophin 1 | 0.010 |